These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 31412669)

  • 21. The Use of Mechanical Circulatory Assist Devices for ACS Patients with Cardiogenic Shock and High-Risk PCI.
    Manian N; Thakker J; Nair A
    Curr Cardiol Rep; 2022 Jun; 24(6):699-709. PubMed ID: 35403950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The evolution of temporary percutaneous mechanical circulatory support devices: a review of the options and evidence in cardiogenic shock.
    Abnousi F; Yong CM; Fearon W; Banerjee D
    Curr Cardiol Rep; 2015 Jun; 17(6):40. PubMed ID: 25899658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feasibility of early mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: The Detroit cardiogenic shock initiative.
    Basir MB; Schreiber T; Dixon S; Alaswad K; Patel K; Almany S; Khandelwal A; Hanson I; George A; Ashbrook M; Blank N; Abdelsalam M; Sareen N; Timmis SBH; O'Neill Md WW
    Catheter Cardiovasc Interv; 2018 Feb; 91(3):454-461. PubMed ID: 29266676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanical Circulatory Support for High-Risk Percutaneous Coronary Intervention.
    Moscardelli S; Masoomi R; Villablanca P; Jabri A; Patel AK; Moroni F; Azzalini L
    Curr Cardiol Rep; 2024 Apr; 26(4):233-244. PubMed ID: 38407792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of Extracorporeal Membrane Oxygenation Combined with Intraaortic Balloon Pump Hemodynamic Support during the Percutaneous Coronary Intervention Process for Patients with Cardiac Shock Complicating Acute Myocardial Infarction.
    Luo M; Zhou J; Qiu C; Wang H; Guan H; Tang Y; Chen Y; Xie J; Zong Y; Dong W; Shang S; Liu G; Si C
    J Healthc Eng; 2022; 2022():1350673. PubMed ID: 35295178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Temporary percutaneous ventricular assist devices for cardiogenic shock and high-risk percutaneous coronary intervention: a systematic literature review].
    Negro A; Pecoraro V; Camerlingo MD; Maltoni S
    G Ital Cardiol (Rome); 2020 Feb; 21(2):128-137. PubMed ID: 32051636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utilization of the Impella for hemodynamic support during percutaneous intervention and cardiogenic shock: an insight.
    Nalluri N; Patel N; Saouma S; Anugu VR; Anugula D; Asti D; Mehta V; Kumar V; Atti V; Edla S; Grewal RK; Khan HM; Kanotra R; Maniatis G; Kandov R; Lafferty JC; Dyal M; Alfonso CE; Cohen MG
    Expert Rev Med Devices; 2017 Oct; 14(10):789-804. PubMed ID: 28862481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Timing of Impella implantation and outcomes in cardiogenic shock or high-risk percutaneous coronary revascularization.
    Tarantini G; Masiero G; Burzotta F; Pazzanese V; Briguori C; Trani C; Piva T; De Marco F; Di Biasi M; Pagnotta P; Mojoli M; Casu G; Giustino G; Lorenzoni G; Montorfano M; Ancona MB; Pappalardo F; Chieffo A;
    Catheter Cardiovasc Interv; 2021 Aug; 98(2):E222-E234. PubMed ID: 33793051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of nonemergent percutaneous coronary intervention requiring mechanical circulatory support in patients without cardiogenic shock.
    Al-Khadra Y; Alraies MC; Darmoch F; Pacha HM; Soud M; Kaki A; Rab T; Grines CL; Meraj P; Alaswad K; Kwok CS; Mamas M; Kapadia S
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):503-512. PubMed ID: 31254325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of mechanical circulatory support devices in patients with acute myocardial infarction undergoing stent implantation: a systematic review and meta-analysis of randomised controlled trials.
    Shi Y; Wang Y; Sun X; Tang Y; Jiang M; Bai Y; Liu S; Jiang W; Yuan H; Lu Y; Cai J
    BMJ Open; 2021 Jun; 11(6):e044072. PubMed ID: 34187815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative Healthcare Resource Utilization of Percutaneous Mechanical Circulatory Support Using Impella Versus Intra-aortic Balloon Pump Use for Patients With Acute Coronary Syndrome and Cardiogenic Shock Undergoing Percutaneous Coronary Interventions: Insights From National Inpatient Sample.
    Dodoo SN; Kwapong YA; Agyemang-Sarpong A; Amoran E; Egolum UO; Ghasemzadeh N; Ramadan R; Henry G; Samady H
    Curr Probl Cardiol; 2024 Jan; 49(1 Pt A):102053. PubMed ID: 37640173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contemporary trends in use of mechanical circulatory support in patients with acute MI and cardiogenic shock.
    Helgestad OKL; Josiassen J; Hassager C; Jensen LO; Holmvang L; Udesen NLJ; Schmidt H; Berg Ravn H; Moller JE
    Open Heart; 2020; 7(1):e001214. PubMed ID: 32201591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry.
    O'Neill WW; Schreiber T; Wohns DH; Rihal C; Naidu SS; Civitello AB; Dixon SR; Massaro JM; Maini B; Ohman EM
    J Interv Cardiol; 2014 Feb; 27(1):1-11. PubMed ID: 24329756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Revascularization Practices and Outcomes in Patients With Multivessel Coronary Artery Disease Who Presented With Acute Myocardial Infarction and Cardiogenic Shock in the US, 2009-2018.
    Khera R; Secemsky EA; Wang Y; Desai NR; Krumholz HM; Maddox TM; Shunk KA; Virani SS; Bhatt DL; Curtis J; Yeh RW
    JAMA Intern Med; 2020 Oct; 180(10):1317-1327. PubMed ID: 32833024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Escalation strategies, management, and outcomes of acute myocardial infarction-cardiogenic shock patients receiving percutaneous left ventricular support.
    Patlolla SH; Gilbert ON; Belford PM; Morris BN; Jentzer JC; Pisani BA; Applegate RJ; Zhao DX; Vallabhajosyula S
    Catheter Cardiovasc Interv; 2023 Sep; 102(3):403-414. PubMed ID: 37473420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Data-driven point-of-care risk model in patients with acute myocardial infarction and cardiogenic shock.
    Helgestad OKL; Povlsen AL; Josiassen J; Möller S; Hassager C; Jensen LO; Holmvang L; Schmidt H; Møller JE; Ravn HB
    Eur Heart J Acute Cardiovasc Care; 2021 Aug; 10(6):668-675. PubMed ID: 34151353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. When to Achieve Complete Revascularization in Infarct-Related Cardiogenic Shock.
    Masiero G; Cardaioli F; Rodinò G; Tarantini G
    J Clin Med; 2022 May; 11(11):. PubMed ID: 35683500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock.
    Babaev A; Frederick PD; Pasta DJ; Every N; Sichrovsky T; Hochman JS;
    JAMA; 2005 Jul; 294(4):448-54. PubMed ID: 16046651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deploying Mechanical Circulatory Support Via the Axillary Artery in Cardiogenic Shock and High-Risk Percutaneous Coronary Intervention.
    Kajy M; Laktineh A; Blank N; Tayal R; Tanveer S; Mohamad T; Elder M; Schreiber T; Kaki A
    Am J Cardiol; 2020 Aug; 128():127-133. PubMed ID: 32650906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gender disparities with the use of percutaneous left ventricular assist device in patients undergoing percutaneous coronary intervention complicated by cardiogenic shock: From pVAD Working Group.
    Doshi R; Patel K; Decter D; Jauhar R; Meraj P
    Indian Heart J; 2018 Jul; 70 Suppl 1(Suppl 1):S90-S95. PubMed ID: 30122245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.